Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer-Reference-Cited by-同舟云学术

Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer

Published:1993-01 Issue:4 Volume:29 Page:497-500
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fornander Tommy,Rutqvist Lars E.,Wilking Nils,Carlström K.,von Schoultz B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Randomised trial of chemoendocrine therapy, endocrine therapy and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis;Lancet,1984

2. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. Preliminary Analysis by the CRC Adjuvant Breast Trial Working Party;CRC Adjuvant Breast Trial Working Party;Br J Cancer,1988

3. Controlled trial of tamoxifen as single adjuvant agent in the management of early breast cancer. Analysis at Eight Years by “Nolvadex” Adjuvant Trial Organisation;Baum;Br J Cancer,1988

4. The Christie hospital adjuvant tamoxifen trial: status at 10 years;Ribeiro;Br J Cancer,1988

5. Antitumor activity of antiestrogen ICI 46,474 (tamoxifen) in dimethylbenzantracene (DMBA)-induced rat mammary carcinoma model;Jordan;J Steroid Biochem,1974

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer;Breast Cancer Research and Treatment;2012-12-15

2. Pure Antiestrogens;Hormone Therapy in Breast and Prostate Cancer;2009

3. Bone health in postmenopausal women with early breast cancer: How protective is tamoxifen?;Cancer Treatment Reviews;2007-10

4. Oral 17β-estradiol and sequential progesterone in menopause: Effects on insulin-like growth factors and their binding proteins;Gynecological Endocrinology;2007-01

5. Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting;Current Opinion in Oncology;2005-11